Antigen delivery vectors and constructs

Details for Australian Patent Application No. 2005232428 (hide)

Owner Immune Targeting Systems

Inventors Brown, Carlton B.; Georges, Bertrand; Sizer, Philip J.; Bonnet, Dominique

Agent Pegasus IP

Pub. Number AU-B-2005232428

PCT Pub. Number WO2005/099752

Priority 0408164.2 13.04.04 GB

Filing date 1 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 24 June 2010

International Classifications

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/099752 Priority application(s): WO2005/099752

24 June 2010 Application Accepted

  Published as AU-B-2005232428

5 August 2010 Alteration of Name

  The name of the applicant has been altered to IMMUNE TARGETING (ITS) SYSTEMS LIMITED 2006

21 October 2010 Standard Patent Sealed

28 October 2010 Alteration of Name

  The name of the applicant has been altered to Immune Targeting Systems (ITS) Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232429-Cleaning apparatus

2005232420-Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity